Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
Technology appraisal guidance
Reference number: TA705
Published:
Please note that following on from communications with the company, the timelines for this appraisal have now been updated.
The new committee date will be Thursday 11 March 2021.